Cadrenal Therapeutics Inc (CVKD)
0.4511
+0.02
(+4.79%)
USD |
NASDAQ |
Apr 29, 16:00
0.4411
-0.01
(-2.22%)
After-Hours: 07:57
Cadrenal Therapeutics Total Liabilities (Quarterly): 0.8269M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.8269M |
| September 30, 2023 | 0.5658M |
| June 30, 2023 | 0.3831M |
| March 31, 2023 | 0.4168M |
| Date | Value |
|---|---|
| December 31, 2022 | 6.329M |
| September 30, 2022 | 1.725M |
| June 30, 2022 | 0.9142M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.3831M
Minimum
Jun 2023
6.329M
Maximum
Dec 2022
1.594M
Average
0.8269M
Median
Dec 2023
Total Liabilities (Quarterly) Benchmarks
| Tenax Therapeutics Inc | 3.586M |
| Syra Health Corp | 0.9101M |
| Relmada Therapeutics Inc | 12.19M |
| Minerva Neurosciences Inc | 85.36M |
| Adverum Biotechnologies Inc | 89.54M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 8.519M |
| Shareholders Equity (Quarterly) | 7.692M |